This research study assesses the effects of virtual reality-based light intensity (mild) exercise activity on symptoms in patients after surgery for suspected non-small cell lung cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03724331.
PRIMARY OBJECTIVES:
I. Determine efficacy by comparing the immediate intervention group with waitlist control (usual care) and attention control by age.
II. Determine efficacy of initiating the exercise intervention 6 wks post-discharge and compare results with the immediate intervention group for all ages.
III. Determine the immediate interventions sustainability by analyzing rates of extension, adherence, and retention; acceptability; and efficacy of primary and secondary outcomes.
OUTLINE: Patients are randomized to 1 of 3 groups.
Light Physical Activity Program Group 1: After hospital discharge for surgery for suspected non-small cell lung cancer, patients participate in light physical activity via virtual reality based exercise gradually increasing in duration for 5 days weekly starting within the first week after discharge from the hospital for six weeks, as directed by a Registered Nurse. Participants commit to continue participating in the light physical activity for another six weeks (weeks 7 to 12 after surgery).
Light Physical Activity Program Group 2: After hospital discharge for surgery for suspected non-small cell lung cancer, patients participate in light physical activity via a virtual reality based exercise gradually increasing from 5 to 30 minutes at home for 5 days weekly starting approximately 7 weeks after discharge from the hospital for six weeks, as guided by a Registered Nurse.
Support Education Activity Program Group: After hospital discharge for surgery for suspected non-small cell lung cancer, patients participate in a cancer-related education activity consisting of a phone conversation with a Registered Nurse for 10 to 15 minutes each week for six weeks.
Trial PhasePhase III
Trial Typesupportive care
Lead OrganizationUniversity of Nebraska Medical Center
Principal InvestigatorKevin Kupzyk